Charles Li
Director/Board Member bei EKSO BIONICS HOLDINGS, INC.
Vermögen: 37 275 $ am 31.03.2024
Profil
Charles Li is currently an Independent Director at Ekso Bionics Holdings, Inc. and the Chief Business Officer at Angel Pharmaceuticals Co., Ltd.
He holds a doctorate degree from Harvard University and an undergraduate degree from Xi'an Jiaotong University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 14.04.2023 | 27 408 ( 0,15% ) | 37 275 $ | 31.03.2024 |
Aktive Positionen von Charles Li
| Unternehmen | Position | Beginn |
|---|---|---|
| EKSO BIONICS HOLDINGS, INC. | Director/Board Member | 11.03.2018 |
Angel Pharmaceuticals Co., Ltd.
 Angel Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Angel Pharmaceuticals Co., Ltd. operates as a biopharmaceutical company which develops medicines for treatment of cancer, autoimmune and infectious diseases. The company was founded by Richard Miller and Ted Wang on October 5, 2020 and is headquartered in Shanghai, China. | Corporate Officer/Principal | 10.10.2020 |
Ausbildung von Charles Li
| Harvard University | Doctorate Degree |
| Xi'an Jiaotong University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| EKSO BIONICS HOLDINGS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Angel Pharmaceuticals Co., Ltd.
Angel Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Angel Pharmaceuticals Co., Ltd. operates as a biopharmaceutical company which develops medicines for treatment of cancer, autoimmune and infectious diseases. The company was founded by Richard Miller and Ted Wang on October 5, 2020 and is headquartered in Shanghai, China. | Health Technology |
